Recursion Pharmaceuticals Shares Trading at $4.67 as AI Drug Discovery Thesis Gains Attention
Recursion Pharmaceuticals stock traded at $4.67 on January 16. A bullish investment thesis highlights its AI platform and Nvidia partnership, positioning it in the AI pharmaceutical sector.